Latest Ratings for VRDN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | JMP Securities | Maintains | Market Outperform | |
| Nov 2021 | SVB Leerink | Initiates Coverage On | Outperform | |
| Nov 2021 | JMP Securities | Maintains | Market Outperform |
Expert Outlook: Viridian Therapeutics Through The Eyes Of 10 Analysts
